We previously showed that nuclear DNA replication (NDR) is regulated by a checkpoint monitoring the occurrence of organelle DNA replication (ODR) in a unicellular red alga Cyanidioschyzon merolae. These analyses depended on the use of chemical CDK inhibitors such as CDK2 inhibitor II and roscovitine, but subsequent analyses yielded conflicting results depending on the experimental conditions. In the present study, we identified significantly short half-lives of the used chemicals in the sulfur acidic cultivation medium, which reconciles the discrepancy among these results.Cyanidioschyzon merolae is a unicellular red alga living in acidic hot springs, and was introduced as a novel model eukaryotic cell to elucidate various fundamental cell processes because it contains the simplest structure among eukaryotic cells. The complete genome sequences of the nucleus, mitochondria, and chloroplast were determined, and various tools for molecular genetics analyses have been developed (Fujiwara et al., 2013;Imamura et al., 2009;Kobayashi et al., 2010;Kuroiwa, 1998;Matsuzaki et al., 2004;Nozaki et al., 2007;Taki et al., 2015). C. merolae has been extensively used for studying organelle division processes, cell cycle regulation, and structural biology.In a previous study, we investigated a mechanism underlying the coordination of organelle DNA replication (ODR) with nuclear DNA replication (NDR) in C. merolae (Kobayashi et al., 2009). Under periodic light-dark cultivation conditions, the algal cell cycle is arrested at the G1 phase in the dark, and initiated by illumination. Detailed analyses revealed that both mitochondria and chloroplast genomes replicate upon the onset of illumination, and then NDR occurs afterward. As the underlying mechanism, we revealed that an increase of intracellular Mg-ProtoIX, an intermediate of chlorophyll biosynthesis produced in the chloroplast, induced by the ODR occurrence was recognized as a retrograde signal from the chloroplast to the nucleus to activate CDKA, responsible for activating NDR.During these experiments, specific inhibitors for cyclin-dependent kinases (CDK) were conveniently used to analyze the underlying mechanism. CDK2 inhibitor II is a commercially available inhibitor for animal CDK2 and plant CDKA (Merck, Darmstadt, Germany) (Davis et al., 2001). As expected, biochemical and physiological analyses revealed that this compound inhibited the relevant CDK (CDKA) activity and NDR in C. merolae (Kobayashi et al., 2009). Another CDK inhibitor used was roscovitine (Merck, Darmstadt, Germany), that is known as a general inhibitor for various CDK types, as revealed by its inhibition of cdc2/cyclin B, cdk2/cyclin A, cdk2/cyclin E, and cdk5/p53 in mammalian cells (Xie et al., 2016). Our results indicated that CDK inhibitor II inhibited only NDR, while roscovitine inhibited both ODR and NDR, and, thus, it was suggested that ODR is under the control of a CDK other than CDKA in C.merolae. Because both CDK inhibitors inhibit NDR at the cell cycle S phase, their addition to the ...